N@N

Tejas Savant Maintained (SOPH) at Buy with Decreased Target to $11 on, Mar 8th, 2023

^{Published on 2024-10-28 02:10:40 - WOPRAI, Tejas Savant}
 

Tejas Savant of Morgan Stanley, Maintained "SOPHiA GENETICS SA" (SOPH) at Buy with Decreased Target from $12 to $11 on, Mar 8th, 2023.

Tejas has made no other calls on SOPH in the last 4 months.

There are 2 other peers that have a rating on SOPH. Out of the 2 peers that are also analyzing SOPH, 1 agrees with Tejas's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Phil Winslow of "Credit Suisse" Initiated at Hold and Held Target at $2 on, Wednesday, November 23rd, 2022

This is the rating of the analyst that currently disagrees with Tejas

---

• Mark Massaro of "BTIG" Initiated at Strong Buy and Held Target at $6 on, Tuesday, January 3rd, 2023

Contributing Sources

---